Clinical Trials Directory

Trials / Unknown

UnknownNCT03296176

Metabolomic Study in Huntington's Disease (METABO-HD)

Metabolomic Study in Huntington's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

The purpose of this project is to study Huntington's disease by metabolomic approach.

Conditions

Interventions

TypeNameDescription
BIOLOGICALblood sampleblood sample for metabolome analyse

Timeline

Start date
2017-10-09
Primary completion
2019-09-01
Completion
2019-09-01
First posted
2017-09-28
Last updated
2017-11-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03296176. Inclusion in this directory is not an endorsement.

Metabolomic Study in Huntington's Disease (METABO-HD) (NCT03296176) · Clinical Trials Directory